Skip to main content
logo
Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.330
-0.120 (-2.70%)
At close: Jul 24, 2026, 4:00 PM EDT
4.340
+0.010 (0.23%)
Pre-market: Jul 27, 2026, 5:44 AM EDT

Zentalis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
308932161,0721,1943,824
Market Cap Growth
183.70%-56.82%-79.85%-10.20%-68.78%79.39%
Enterprise Value
135.13-116.92-115.52632.44801.923,529
Last Close Price
4.331.353.0315.1520.1484.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.690.430.642.452.7510.51
P/TBV Ratio
1.700.450.642.292.489.96

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
-0.770.61---
EV/EBIT Ratio
-0.770.60---
EV/FCF Ratio
-0.930.68---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.170.120.100.100.12
Net Debt / Equity Ratio
-0.97-0.97-0.98-1.01-0.90-0.81
Net Debt / EBITDA Ratio
1.231.381.751.481.741.37
Net Debt / FCF Ratio
1.411.681.942.112.361.84
Quick Ratio
6.016.737.136.967.727.73
Current Ratio
6.196.937.327.167.987.98
Return on Equity (ROE)
-62.24%-49.53%-42.83%-67.09%-59.39%-47.60%
Return on Assets (ROA)
-53.76%-42.63%-38.98%-54.79%-45.64%-52.72%
Return on Invested Capital (ROIC)
-2514.88%-2621.90%-11596.38%-1515.47%-409.13%-664.85%
Return on Capital Employed (ROCE)
-61.69%-48.51%-44.47%-62.08%-50.89%-57.94%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-0.34%-1.11%-8.67%-23.75%-23.82%-51.84%
Total Shareholder Return
-0.34%-1.11%-8.67%-23.75%-23.82%-51.84%
SEC Filings: 10-K · 10-Q